Sangamo Therapeutics Inc
NASDAQ:SGMO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
CIMC Enric Holdings Ltd
HKEX:3899
|
CN |
|
Hyzon Motors Inc
NASDAQ:HYZN
|
US |
|
Shun Tak Holdings Ltd
HKEX:242
|
HK |
|
E
|
EcoUp Oyj
OMXH:ECOUP
|
FI |
|
China Citic Bank Corp Ltd
SSE:601998
|
CN |
During the last 3 months Sangamo Therapeutics Inc insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 36% over this period ( loading = false, 5000)" href="https://www.alphaspread.com/comparison/nasdaq/sgmo/vs/indx/gspc">open performance analysis).
The last transaction was made on
Sep 26, 2023
by
Biogen Inc.
, who
sold
3m USD
worth of
SGMO shares.
During the last 3 months Sangamo Therapeutics Inc insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 36% over this period ( loading = false, 5000)" href="https://www.alphaspread.com/comparison/nasdaq/sgmo/vs/indx/gspc">open performance analysis).
The last transaction was made on
Sep 26, 2023
by
Biogen Inc.
, who
sold
3m USD
worth of
SGMO shares.
Sangamo Therapeutics Inc
Glance View
Sangamo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the research and development of zinc finger proteins. The company is headquartered in Brisbane California, California and currently employs 431 full-time employees. The company went IPO on 2000-04-06. The firm focuses on leveraging its optimized zinc finger (ZF) technology, which is a differentiated tool used to develop genomic medicines, including allogeneic cell therapies and in vivo genome engineering therapies. Its product candidates include Isaralgagene civaparvovec, also known as ST-920, its wholly owned gene therapy product candidate for the treatment of Fabry disease; SAR445136, its ZF nuclease, gene-edited cell therapy product candidate for the treatment of sickle cell disease (SCD); TX200, its wholly owned Chimeric Antigen Receptor (CAR) engineered regulatory T cell (CAR-Treg), cell therapy product candidate for the prevention of immune-mediated rejection in HLA-A2 mismatched kidney transplantation; Giroctocogene fitelparvovec, also known as SB-525, is a gene therapy product candidate for the treatment of moderately severe to severe hemophilia A.
What is Insider Trading?
Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.
While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.
Why is Insider Trading Important?
It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.
However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.